• Explore /
  • Poster
  • / A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress.

A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress.

Abstract Poster

Authors

Chinmay Jani

Chinmay Jani

Mount Auburn Hospital , Harvard Medical School, Cambridge, MA

Chinmay Jani , Wanling Xie , Archana Ajmera , Arlene Araneta , Christina Jamieson , Edmund Folefac , Arif Hussain , Christos Kyriakopoulos , Adam C. Olson , Mamta Parikh , Rahul Atul Parikh , Biren Saraiya , Salma K. Jabbour , S. Percy Ivy , Eliezer Mendel Van Allen , Neal Ian Lindeman , Bose Kochupurakkal , Geoffrey Shapiro , Rana R. McKay

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT03317392

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS5110)

DOI

10.1200/JCO.2023.41.16_suppl.TPS5110

Abstract #

TPS5110

Poster Bd #

198a

Abstract Disclosures

Similar Posters

First Author: Rana R. McKay

First Author: Justin Shaya

First Author: Syed Arsalan Ahmed Naqvi

First Author: Fadi Taza